Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils Kurzen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|June 30, 2026
CURE: a phase-based therapeutic framework for chronic inflammationNils Kurzen, Stefan Weißinger, Hjalmar Kurzen
Dermatology and Therapy|March 24, 2026
A Retrospective Real-World Comparison of Topical Delgocitinib and Localized Cream Psoralen-Ultraviolet A in Chronic Hand EczemaStefan Weißinger, Eva Oppel, Nils Kurzen, et al.
The British Journal of Dermatology|August 12, 2025
TYK2 inhibition improves clinical and molecular hallmarks in various subtypes of cutaneous lupusSophia Wasserer, Peter Seiringer, Nils Kurzen, et al.
The Journal of Investigative Dermatology|January 2, 2025
Death-Associated Protein Kinase 1 Dampens Keratinocyte Necroptosis and Expression of Inflammatory Genes in Lichen PlanusNils Kurzen, Menna Mubarak, Jessica Eigemann, et al.
The Journal of Allergy and Clinical Immunology|February 19, 2026
Inhibition of RIPK1 prevents keratinocyte cell death and reduces skin inflammation in type 1 mediated chronic inflammatory skin diseasesManja Jargosch, Sophia Wasserer, Jessica Eigemann, et al.
The British Journal of Dermatology|April 20, 2026
Proliferation-associated protein 2G4 promotes keratinocyte proliferation and survival in psoriasisTheresa Raunegger, Sophia Wasserer, Jessica Eigemann, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|June 30, 2026
CURE: a phase-based therapeutic framework for chronic inflammationNils Kurzen, Stefan Weißinger, Hjalmar Kurzen
Dermatology and Therapy|March 24, 2026
A Retrospective Real-World Comparison of Topical Delgocitinib and Localized Cream Psoralen-Ultraviolet A in Chronic Hand EczemaStefan Weißinger, Eva Oppel, Nils Kurzen, et al.
The British Journal of Dermatology|August 12, 2025
TYK2 inhibition improves clinical and molecular hallmarks in various subtypes of cutaneous lupusSophia Wasserer, Peter Seiringer, Nils Kurzen, et al.
The Journal of Investigative Dermatology|January 2, 2025
Death-Associated Protein Kinase 1 Dampens Keratinocyte Necroptosis and Expression of Inflammatory Genes in Lichen PlanusNils Kurzen, Menna Mubarak, Jessica Eigemann, et al.
The Journal of Allergy and Clinical Immunology|February 19, 2026
Inhibition of RIPK1 prevents keratinocyte cell death and reduces skin inflammation in type 1 mediated chronic inflammatory skin diseasesManja Jargosch, Sophia Wasserer, Jessica Eigemann, et al.
The British Journal of Dermatology|April 20, 2026
Proliferation-associated protein 2G4 promotes keratinocyte proliferation and survival in psoriasisTheresa Raunegger, Sophia Wasserer, Jessica Eigemann, et al.
Pageof 1